The Globe and Mail reports in its Wednesday edition that Raymond James analyst Stephen Boland has boosted Canaccord Genuity Group to "strong buy" from "outperform." The Globe's David Leeder writes that Mr. Boland gave his share target a $1.50 boost to $11. Analysts on average target the shares at $10.19. Mr. Boland says he sees an "excellent asymmetric risk/reward opportunity with limited downside risk" at Canaccord. Mr. Boland says in a note: "While we acknowledge the danger in reading too much into short-term [positive] market movements, we believe the stock reaction suggests we may have reached the point of maximum pessimism for Canaccord and this may have put a floor on the stock. With what we see as downside protection, we now believe Canaccord investors are effectively getting a free call option on the resurgence in new issue activity. ... We understand many investors will be hesitant to buy Canaccord before there is a visible improvement in capital markets activity. This is an obvious concern for many. However, we believe that 'waiting' could lead to (1) a significant loss of upside given the torque of Canaccord's stock or (2) mistaking a temporary resurgence in activity for a more prolonged recovery."